San Francisco-based Parker Institute for Cancer Immunotherapy on April 10 published its first major scientific findings since launching in April 2016.
In the paper, published in Nature, scientists from Philadelphia-based University of Pennsylvania and New York City-based Memorial Sloan Kettering Cancer Center detail a new method to predict whether skin cancer patients will respond to certain immunotherapy treatments.
Silicon Valley entrepreneur and philanthropist Sean Parker, who co-founded Napster and served as Facebook's founding president, founded the Parker Institute. Today, Mr. Parker serves as the organization's chairman of the board.
Click here to view the full paper.